Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration
Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration
批准号:
8656346
负责人:
Goldis Malek
金额:
$33.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2016-04-30
关键词:
AffectAgeAge related macular degenerationAnimal ModelBiogenesisBiological AssayBlindnessCD36 geneCell Culture TechniquesCell physiologyCellsCellular Metabolic ProcessCholesterolClinicalCollagen Type IVCoupledDataDepositionDevelopmentDietDietary FatsDietary Fatty AcidDietary intakeDiseaseElderlyEpithelialExtracellular MatrixFamilyFatty AcidsFunctional disorderGene ExpressionGene TargetingGenesGoalsGrantHumanIn VitroIndividualInjuryLaboratoriesLeadLigandsLinkLipidsLipoproteinsMediatingMindMitochondriaModelingMolecularMusNuclear ReceptorsOrganellesOxidantsPathologicPathologyPathway interactionsPeroxisome ProliferationPeroxisome Proliferator-Activated ReceptorsPhenotypePlayPolyunsaturated Fatty AcidsProcessProductionProtein IsoformsProteinsReactive Oxygen SpeciesReceptor SignalingRegulator GenesRetinal PigmentsRiskRisk FactorsRoleSignal PathwayTestingTherapeuticTherapeutic EffectUnsaturated Fatty AcidsUp-RegulationWestern Worldbasedesignepidemiology studyextracellularfatty acid oxidationin vivomitochondrial dysfunctionmouse modelparticlepatient populationperoxisomepreventpublic health relevancesecretion processsensorstressortherapeutic development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The cellular and molecular pathways of sub-retinal pigment epithelial (sub-RPE) deposit formation, the hallmark of the early 'dry' form of age-related macular degeneration (AMD), and the leading cause of vision loss in the elderly, are not known. Epidemiology studies have identified age, n-6 polyunsaturated fatty acid (PUFA) dietary intake and oxidant injury as risks for AMD. Further, studies from several laboratories, including our own, suggest that pathways regulating lipid and cholesterol processing and secretion play a pivotal role in deposit formation. However, the link between dietary intake of PUFAs and signaling pathways that promote production of deposits formation is not known. Our goal therefore is to identify the pathogenic mechanisms by which lipids, including PUFAs, regulate deposit formation. Peroxisome proliferator activating receptors (PPARs) are nuclear receptors that act as lipid sensors. Of the three isoforms, PPAR¿/d mediates the regulatory effects of dietary fatty acids, including n-6 PUFAs, on gene expression and stimulates the proliferation of peroxisomes, organelles involved in fatty acid oxidation. PPAR transcriptional activity is coupled with upregulation of molecules associated with cholesterol and lipid efflux, altered extracellular matrix (ECM) synthesis, and mitochondrial dysfunction; these families of molecules are also associated with deposit formation. With this in mind, we asked a corollary question: does dietary lipid activation of the PPAR¿/d signaling pathway in RPE cells stimulate deposit formation? In our preliminary studies, we found that exposure of RPE cell cultures to native and oxidized derivatives of n-6 PUFAs resulted in profound cellular changes in the expression of molecules associated with and regulating deposit formation. The changes included (1) increased synthesis and secretion of ECM molecule collagen IV; (2) increased expression of cholesterol and lipid efflux regulatory genes ABCA1 and CD36; (3) accumulation of damaged mitochondria and reactive oxygen species; (4) activation of PPAR ¿/d; and (5) upregulation of PPAR¿/d specific target genes regulating ECM molecules, and lipid secretion. Based on this preliminary data, we hypothesize that dietary n-6 fatty acids stimulate production of molecules found in deposits through activation of PPAR¿/d and increased proliferation of peroxisomes. Accumulation of deposits requires lipid and cholesterol secretion by the RPE and dysregulated synthesis of ECM molecules by the RPE, leads to trapping of lipids. We further propose that additional 'stressors' on the PPAR¿/d pathway (i.e., age, oxidants) lead to upregulation of these processes and further compromise RPE cell function, mediated by mitochondrial dysfunction. To test this hypothesis we will use a combination of cell culture assays with human RPE cells and mouse models of deposits to investigate the role of PPARs in deposit formation. We will also investigate if decreasing activity of PPAR¿/d can slow the progression of AMD in murine models of deposit formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
-
批准号:10679287
-
项目类别:
-
资助金额:$45.47万
-
财政年份:2023
-
负责人:Goldis Malek
-
依托单位:
Nuclear receptor driven mechanisms in aging and AMD
-
批准号:10672924
-
项目类别:
-
资助金额:$47.27万
-
财政年份:2021
-
负责人:Goldis Malek
-
依托单位:
Nuclear receptor driven mechanisms in aging and AMD
-
批准号:10448330
-
项目类别:
-
资助金额:$45.85万
-
财政年份:2021
-
负责人:Goldis Malek
-
依托单位:
Regulation of inflammation and lipid homeostasis by the aryl hydrocarbon receptor in age-related macular degeneration
-
批准号:9542513
-
项目类别:
-
资助金额:$44.43万
-
财政年份:2018
-
负责人:Goldis Malek
-
依托单位:
Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration
-
批准号:8258719
-
项目类别:
-
资助金额:$39.85万
-
财政年份:2011
-
负责人:Goldis Malek
-
依托单位:
Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration
-
批准号:8461947
-
项目类别:
-
资助金额:$36.48万
-
财政年份:2011
-
负责人:Goldis Malek
-
依托单位:
Lipid Activated Nuclear Receptors in Age-Related Macular Degeneration
-
批准号:8107771
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:Goldis Malek
-
依托单位:
Animal Models Module
-
批准号:10273185
-
项目类别:
-
资助金额:$14.86万
-
财政年份:1997
-
负责人:Goldis Malek
-
依托单位:
Animal Models Core
-
批准号:10006548
-
项目类别:
-
资助金额:$11.04万
-
财政年份:1997
-
负责人:Goldis Malek
-
依托单位:
Animal Models Module
-
批准号:10472751
-
项目类别:
-
资助金额:$14.86万
-
财政年份:1997
-
负责人:Goldis Malek
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: